PACIFIC BIOSCIENCES OF CALIFORNIA
(NASDAQ: PACB)

Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.

1.970 s

+0.040 (+2.07%)
Range 1.850 - 2.010   (8.65%)
Open 1.870
Previous Close 1.930
Bid Price 12.600
Bid Volume 14
Ask Price 12.610
Ask Volume 22
Volume 10,827,548
Value -
Remark s
Delayed prices. Updated at 21 Dec 2024 05:00.
Data powered by
View All Events

About PACIFIC BIOSCIENCES CALIFORNIA INC

Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.

Loading Chart...

Please login to view stock data and analysis